Survival analysis and end-points:
The primary end-point of our study was a composite end-point of major
cardiovascular events comprising left ventricular assisted device
implantation, heart transplantation, and all-cause mortality. LV
systolic function recovery is defined as improving
LVEF>10% and increasing over 40%. A total of 37 patients
were included in the study.